MCL coexpression mm9:1890: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
|ontology_enrichment_disease= | |ontology_enrichment_disease= | ||
|ontology_enrichment_uberon=UBERON:0002193!1.94e-21!48;UBERON:0002405!1.94e-21!48;UBERON:0002390!5.64e-20!45;UBERON:0003061!5.64e-20!45;UBERON:0001007!1.63e-11!116;UBERON:0001555!1.63e-11!116;UBERON:0007026!1.63e-11!116;UBERON:0004119!2.70e-11!118;UBERON:0000925!2.70e-11!118;UBERON:0006595!2.70e-11!118;UBERON:0004921!7.12e-11!114;UBERON:0004177!1.46e-10!29;UBERON:0005057!1.46e-10!29;UBERON:0002371!1.70e-10!16;UBERON:0001474!5.28e-09!22;UBERON:0004765!5.28e-09!22;UBERON:0001434!5.28e-09!22;UBERON:0001041!7.73e-09!80;UBERON:0000077!8.41e-09!35;UBERON:0002384!1.70e-08!46;UBERON:0003408!4.00e-08!24;UBERON:0003081!5.26e-08!87;UBERON:0002370!1.02e-07!23;UBERON:0000974!1.02e-07!23;UBERON:0004807!1.02e-07!23;UBERON:0005058!1.02e-07!23;UBERON:0003351!1.02e-07!23;UBERON:0009113!1.02e-07!23;UBERON:0003295!1.02e-07!23;UBERON:0009722!1.02e-07!23;UBERON:0005562!1.02e-07!23;UBERON:0007690!1.02e-07!23;UBERON:0006562!1.29e-07!24;UBERON:0001557!1.29e-07!24;UBERON:0001042!1.29e-07!24;UBERON:0008814!1.29e-07!24;UBERON:0009145!1.29e-07!24;UBERON:0002204!7.42e-07!32 | |ontology_enrichment_uberon=UBERON:0002193!1.94e-21!48;UBERON:0002405!1.94e-21!48;UBERON:0002390!5.64e-20!45;UBERON:0003061!5.64e-20!45;UBERON:0001007!1.63e-11!116;UBERON:0001555!1.63e-11!116;UBERON:0007026!1.63e-11!116;UBERON:0004119!2.70e-11!118;UBERON:0000925!2.70e-11!118;UBERON:0006595!2.70e-11!118;UBERON:0004921!7.12e-11!114;UBERON:0004177!1.46e-10!29;UBERON:0005057!1.46e-10!29;UBERON:0002371!1.70e-10!16;UBERON:0001474!5.28e-09!22;UBERON:0004765!5.28e-09!22;UBERON:0001434!5.28e-09!22;UBERON:0001041!7.73e-09!80;UBERON:0000077!8.41e-09!35;UBERON:0002384!1.70e-08!46;UBERON:0003408!4.00e-08!24;UBERON:0003081!5.26e-08!87;UBERON:0002370!1.02e-07!23;UBERON:0000974!1.02e-07!23;UBERON:0004807!1.02e-07!23;UBERON:0005058!1.02e-07!23;UBERON:0003351!1.02e-07!23;UBERON:0009113!1.02e-07!23;UBERON:0003295!1.02e-07!23;UBERON:0009722!1.02e-07!23;UBERON:0005562!1.02e-07!23;UBERON:0007690!1.02e-07!23;UBERON:0006562!1.29e-07!24;UBERON:0001557!1.29e-07!24;UBERON:0001042!1.29e-07!24;UBERON:0008814!1.29e-07!24;UBERON:0009145!1.29e-07!24;UBERON:0002204!7.42e-07!32 | ||
|tfbs_overrepresentation_for_novel_motifs=0.641384,0.402508,0.612053,0.688265,1.21364,0.704257,0.803568,0.96814,0.381467,0.162942,0.755749,0.790506,0.37041,0.81685,0.502646,0,1.02248,0.473993,0.352304,0.24402,0.570433,0.197567,0.815872,0.481455,0.620553,0.846564,0.906602,0.727368,1.32554,0.790816,0.711848,1.12823,0.471365,0.318879,0.503207,0.623685,0.460474,0.786577,0.434783,0.40068,0.478558,0.717547,0.544696,0.504971,0.325217,0.675898,0.938241,0.744678,0.49007,0.539131,1.0041,0.875451,0.282443,1.2746,1.29252,0.82458,0.549352,0.776619,0.331485,0.822375,1.10737,0.885556,0.39557,0.992216,0.8366,1.03484,1.43193,1.78579,1.1025,1.63712,0.590754,0.377213,0.593145,1.32691,0.323563,0.834514,0.318792,0.926147,1.08947,0.575233,0.986898,1.04072,0.884013,0.951203,1.20828,0.11855,0.129654,0.290918,0.943446,1.94914,1.50286,1.21342,1.14153,0.490141,1.09896,1.05366,0.367176,1.14445,0.938512,1.34553,0.460566,1.12793,1.25667,1.00472,1.00361,0.717061,1.06633,0.740267,0.580757,0.57247,0.633483,1.25851,0.576517,0.7614,1.51002,0.476467,0.143825,0.692434,1.02384,0.456123,1.33244,0.970073,0.848526,0.925183,1.56496,1.09333,0.812403,1.13449,1.43038,0.493609,1.23918,0.680176,1.40022,0.839311,1.53196,4.04103,0.650785,0.719099,1.482,2.31884,1.91709,1.43673,0.861473,1.1391,0.996781,0.718046,0.941555,2.27909,0.653418,0.485304,0.293812,0.184289,1.27621,1.069,0.838313,1.35996,0.87653,1.28473,0.63863,0.650472,1.49167,1.20739,1.09379,0.630949,0.993294,0.830321,0.459159,0.788782,0.280875 | |||
}} | }} |
Revision as of 20:35, 26 November 2012
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr10:33847761..33847786,- | p1@Fam26f |
Mm9::chr12:109873953..109874049,+ | p3@Evl |
Mm9::chr6:125021344..125021363,+ | p2@Lpar5 |
Mm9::chr9:108959809..108959823,+ | p@chr9:108959809..108959823 + |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0045010 | actin nucleation | 0.0102266294125167 |
GO:0005522 | profilin binding | 0.0102266294125167 |
GO:0017124 | SH3 domain binding | 0.0102266294125167 |
GO:0030168 | platelet activation | 0.0102266294125167 |
GO:0030048 | actin filament-based movement | 0.0102266294125167 |
GO:0051016 | barbed-end actin filament capping | 0.0102266294125167 |
GO:0051693 | actin filament capping | 0.0102266294125167 |
GO:0030835 | negative regulation of actin filament depolymerization | 0.0102266294125167 |
GO:0030834 | regulation of actin filament depolymerization | 0.0102266294125167 |
GO:0030042 | actin filament depolymerization | 0.0102266294125167 |
GO:0005925 | focal adhesion | 0.0102266294125167 |
GO:0008064 | regulation of actin polymerization and/or depolymerization | 0.0102266294125167 |
GO:0005924 | cell-substrate adherens junction | 0.0102266294125167 |
GO:0051261 | protein depolymerization | 0.0102266294125167 |
GO:0032535 | regulation of cellular component size | 0.0102266294125167 |
GO:0032956 | regulation of actin cytoskeleton organization and biogenesis | 0.0102266294125167 |
GO:0030832 | regulation of actin filament length | 0.0102266294125167 |
GO:0051493 | regulation of cytoskeleton organization and biogenesis | 0.0102266294125167 |
GO:0033043 | regulation of organelle organization and biogenesis | 0.0102266294125167 |
GO:0051129 | negative regulation of cellular component organization and biogenesis | 0.0102266294125167 |
GO:0030055 | cell-matrix junction | 0.0102266294125167 |
GO:0008154 | actin polymerization and/or depolymerization | 0.0111563229954727 |
GO:0030027 | lamellipodium | 0.0118336711773407 |
GO:0007596 | blood coagulation | 0.0118336711773407 |
GO:0019904 | protein domain specific binding | 0.0118336711773407 |
GO:0051128 | regulation of cellular component organization and biogenesis | 0.0118336711773407 |
GO:0007599 | hemostasis | 0.0118336711773407 |
GO:0050817 | coagulation | 0.0118336711773407 |
GO:0005912 | adherens junction | 0.0129067116033831 |
GO:0051248 | negative regulation of protein metabolic process | 0.0134224511039281 |
GO:0016323 | basolateral plasma membrane | 0.0134224511039281 |
GO:0050878 | regulation of body fluid levels | 0.0134224511039281 |
GO:0031252 | leading edge | 0.0138497781186654 |
GO:0007411 | axon guidance | 0.0138497781186654 |
GO:0042060 | wound healing | 0.0138497781186654 |
GO:0030705 | cytoskeleton-dependent intracellular transport | 0.0167034947071106 |
GO:0007409 | axonogenesis | 0.0246935685814427 |
GO:0030036 | actin cytoskeleton organization and biogenesis | 0.0246935685814427 |
GO:0048667 | neuron morphogenesis during differentiation | 0.0246935685814427 |
GO:0048812 | neurite morphogenesis | 0.0246935685814427 |
GO:0030029 | actin filament-based process | 0.0246935685814427 |
GO:0000904 | cellular morphogenesis during differentiation | 0.0270275205902226 |
GO:0031175 | neurite development | 0.0278259451456849 |
GO:0048666 | neuron development | 0.0301344680022158 |
GO:0001775 | cell activation | 0.0301344680022158 |
GO:0051246 | regulation of protein metabolic process | 0.03067988823755 |
GO:0003779 | actin binding | 0.0315937572488813 |
GO:0032990 | cell part morphogenesis | 0.0326858809300052 |
GO:0030030 | cell projection organization and biogenesis | 0.0326858809300052 |
GO:0048858 | cell projection morphogenesis | 0.0326858809300052 |
GO:0016477 | cell migration | 0.0326858809300052 |
GO:0030182 | neuron differentiation | 0.0326858809300052 |
GO:0009611 | response to wounding | 0.033342670990243 |
GO:0048699 | generation of neurons | 0.0351518719467522 |
GO:0051674 | localization of cell | 0.0351518719467522 |
GO:0006928 | cell motility | 0.0351518719467522 |
GO:0009892 | negative regulation of metabolic process | 0.0351518719467522 |
GO:0008092 | cytoskeletal protein binding | 0.0351518719467522 |
GO:0022008 | neurogenesis | 0.0351518719467522 |
GO:0042995 | cell projection | 0.0372249310615607 |
GO:0030054 | cell junction | 0.0385258924425628 |
GO:0009605 | response to external stimulus | 0.0433477130582158 |
GO:0007010 | cytoskeleton organization and biogenesis | 0.0434238418131477 |
GO:0000902 | cell morphogenesis | 0.0434238418131477 |
GO:0032989 | cellular structure morphogenesis | 0.0434238418131477 |
Relative expression of the co-expression cluster over median <br>Analyst:
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
hematopoietic cell | 1.04e-13 | 32 |
hematopoietic oligopotent progenitor cell | 1.04e-13 | 32 |
hematopoietic stem cell | 1.04e-13 | 32 |
angioblastic mesenchymal cell | 1.04e-13 | 32 |
hematopoietic multipotent progenitor cell | 1.04e-13 | 32 |
hematopoietic lineage restricted progenitor cell | 8.45e-12 | 25 |
leukocyte | 1.58e-09 | 17 |
nongranular leukocyte | 1.58e-09 | 17 |
connective tissue cell | 1.70e-08 | 46 |
mesenchymal cell | 1.70e-08 | 46 |
common myeloid progenitor | 6.89e-08 | 19 |
lymphoid lineage restricted progenitor cell | 6.97e-08 | 12 |
T cell | 2.13e-07 | 11 |
pro-T cell | 2.13e-07 | 11 |
lymphocyte | 4.60e-07 | 13 |
common lymphoid progenitor | 4.60e-07 | 13 |
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |